Literature DB >> 20413532

Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs.

G J Gaschler1, C C J Zavitz, C M T Bauer, M R Stämpfli.   

Abstract

Inflammation is prevalent in all stages of chronic obstructive pulmonary disease, and, furthermore, individuals undergo periods of exacerbation, during which pulmonary inflammation increases, often a result of bacterial infection. The present study investigates the in vivo consequences of cigarette smoke exposure on bacterial challenge with nontypeable Haemophilus influenzae (NTHi). BALB/c and C57 black 6 (C57BL/6) mice were exposed to cigarette smoke once or twice daily for a total period of 8 weeks. Exacerbated inflammation was observed in cigarette smoke-exposed compared to room-air-exposed mice following challenge with live or heat-inactivated NTHi. Accelerated clearance of live NTHi from cigarette smoke-exposed mice was independent of the establishment of chronic inflammation or direct toxic effects of cigarette smoke components on bacteria. Mechanistically, a cell-free factor in the bronchoalveolar lavage fluid contributed to accelerated clearance following passive transfer to naive mice. Further investigation demonstrated increased titres of immunoglobulin A in the bronchoalveolar lavage fluid, but not the blood, of cigarette smoke-exposed mice, including increased titres of NTHi-specific immunoglobulin A, whereas heavy chain joining element (J(H))(-/-) B-cell-deficient cigarette smoke-exposed mice did not demonstrate decreased bacterial burden following challenge. The present results demonstrate that cigarette smoke exposure results in exacerbated inflammation following challenge with NTHi, as well as increased titres of antibodies that contribute to bacterial clearance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413532     DOI: 10.1183/09031936.00113909

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

1.  Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Joanne Sonstein; Jeffrey L Curtis; Uma S Sajjan
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

2.  Why do we need a nonhuman primate model of smoking-induced COPD?

Authors:  Jeffrey L Curtis; Christine M Freeman
Journal:  Am J Pathol       Date:  2015-01-07       Impact factor: 4.307

3.  Impact of cigarette smoke on the human and mouse lungs: a gene-expression comparison study.

Authors:  Mathieu C Morissette; Maxime Lamontagne; Jean-Christophe Bérubé; Gordon Gaschler; Andrew Williams; Carole Yauk; Christian Couture; Michel Laviolette; James C Hogg; Wim Timens; Sabina Halappanavar; Martin R Stampfli; Yohan Bossé
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

4.  Cigarette smoke exposure worsens acute lung injury in antibiotic-treated bacterial pneumonia in mice.

Authors:  Jeffrey E Gotts; Lauren Chun; Jason Abbott; Xiaohui Fang; Naoki Takasaka; Stephen L Nishimura; Matthew L Springer; Suzaynn F Schick; Carolyn S Calfee; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-15       Impact factor: 5.464

5.  IL-1 receptor regulates microRNA-135b expression in a negative feedback mechanism during cigarette smoke-induced inflammation.

Authors:  Sabina Halappanavar; Jake Nikota; Dongmei Wu; Andrew Williams; Carole L Yauk; Martin Stampfli
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

6.  Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology.

Authors:  Jeppe M Larsen; Hanieh S Musavian; Tariq M Butt; Camilla Ingvorsen; Anna H Thysen; Susanne Brix
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

7.  Persistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposure.

Authors:  Mathieu C Morissette; Brian N Jobse; Danya Thayaparan; Jake K Nikota; Pamela Shen; Nancy Renée Labiris; Roland Kolbeck; Parameswaran Nair; Alison A Humbles; Martin R Stämpfli
Journal:  Respir Res       Date:  2014-04-22

8.  Targeting IL-1β and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation.

Authors:  Anke Sichelstiel; Koshika Yadava; Aurélien Trompette; Olawale Salami; Yoichiro Iwakura; Laurent P Nicod; Benjamin J Marsland
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

9.  Impact of inflammation, emphysema, and smoking cessation on V/Q in mouse models of lung obstruction.

Authors:  Brian N Jobse; Cory Ajr McCurry; Mathieu C Morissette; Rod G Rhem; Martin R Stämpfli; Nancy Renée Labiris
Journal:  Respir Res       Date:  2014-04-14

10.  Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.

Authors:  Irene Rodríguez-Arce; Xabier Morales; Mikel Ariz; Begoña Euba; Nahikari López-López; Maider Esparza; Derek W Hood; José Leiva; Carlos Ortíz-de-Solórzano; Junkal Garmendia
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.